BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 34732158)

  • 1. Respiratory symptoms as initial manifestations of interstitial lung disease in clinically amyopathic juvenile dermatomyositis: a case report with literature review.
    Xia J; Jiang G; Jin T; Shen Q; Ma Y; Wang L; Qian L
    BMC Pediatr; 2021 Nov; 21(1):488. PubMed ID: 34732158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical and laboratory features and treatment responses in patients with clinically amyopathic juvenile dermatomyositis and classical juvenile dermatomyositis.
    Gezgin Yıldırım D; Baglan E; Güngörer V; Yıldız C; Tuncez S; Bülbül M; Acar B; Bakkaloğlu SA
    Int J Rheum Dis; 2023 Aug; 26(8):1504-1511. PubMed ID: 37288472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung infection or inflammation-a puzzling case of MDA-5 associated juvenile dermatomyositis.
    Vuppala A; Sondhi M; Umer S
    Pediatr Rheumatol Online J; 2023 Dec; 21(1):147. PubMed ID: 38124190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis.
    Mamyrova G; Kishi T; Targoff IN; Ehrlich A; Curiel RV; Rider LG;
    Rheumatology (Oxford); 2018 Nov; 57(11):1956-1963. PubMed ID: 30016492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report.
    Kishi T; Tani Y; Okiyama N; Mizuochi K; Ichimura Y; Harigai M; Nagata S; Miyamae T
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):34. PubMed ID: 33740993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review.
    Nishi K; Ogura M; Tamai N; Gima M; Ide K; Koinuma G; Kamei K; Ito S
    Pediatr Rheumatol Online J; 2022 Aug; 20(1):60. PubMed ID: 35927666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
    Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
    J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].
    Hou J; Zhou ZX; Li JG; Xu YJ; Ding YC
    Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):928-933. PubMed ID: 31795559
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical characteristics of juvenile dermatomyositis complicated with interstitial lung disease].
    Chen L; Hu Y; Yao Y; Zhen XF; Chen F; He Q; Mo X; Ma SC
    Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):465-9. PubMed ID: 22931947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypomyopathic dermatomyositis associated with interstitial lung disease and good response to mycophenolate mofetil: case-based review.
    Koyama RVL; Braga TKK; da Silva Dias GA; Fujihara S; Fuzii HT; Yoshikawa GT
    Clin Rheumatol; 2017 Aug; 36(8):1919-1926. PubMed ID: 28488124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse Gottron papules in juvenile dermatomyositis: an under recognized clinical entity.
    Jindal AK; Guleria S; Pilania RK; Bishnoi A; Vinay K; Dogra S; Suri D; Rawat A; Singh S
    Rheumatol Int; 2018 Jun; 38(6):1153-1160. PubMed ID: 29721695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical analysis and outcome of interstitial lung disease complicated with juvenile dermatomyositis and juvenile polymyositis.
    Sato S; Uejima Y; Nanbu M; Suganuma E; Takano T; Tanaka R; Kabuki T; Oguma E; Oh-Ishi T; Kawano Y
    Mod Rheumatol; 2017 Jul; 27(4):652-656. PubMed ID: 27588444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management.
    Walling HW; Gerami P; Sontheimer RD
    Paediatr Drugs; 2010; 12(1):23-34. PubMed ID: 20034339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis.
    Kobayashi N; Takezaki S; Kobayashi I; Iwata N; Mori M; Nagai K; Nakano N; Miyoshi M; Kinjo N; Murata T; Masunaga K; Umebayashi H; Imagawa T; Agematsu K; Sato S; Kuwana M; Yamada M; Takei S; Yokota S; Koike K; Ariga T
    Rheumatology (Oxford); 2015 May; 54(5):784-91. PubMed ID: 25288783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and management of clinically amyopathic juvenile dermatomyositis across four academic centers.
    Bradley F; Bayer ML; Co DO; Chiu Y; Huber AM; Ahmad RC; Baris HE; Oberle EJ; Kim S
    Pediatr Dermatol; 2021 Mar; 38(2):413-419. PubMed ID: 33438772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
    Quintana-Ortega C; Remesal A; Ruiz de Valbuena M; de la Serna O; Laplaza-González M; Álvarez-Rojas E; Udaondo C; Alcobendas R; Murias S
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):101-107. PubMed ID: 33019894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis.
    Cao H; Parikh TN; Zheng J
    Clin Rheumatol; 2009 Aug; 28(8):979-84. PubMed ID: 19294477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Janus kinase inhibitors in dermatomyositis: a systematic literature review.
    Paik JJ; Lubin G; Gromatzky A; Mudd PN; Ponda MP; Christopher-Stine L
    Clin Exp Rheumatol; 2023 Mar; 41(2):348-358. PubMed ID: 35766013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study.
    Ye S; Chen XX; Lu XY; Wu MF; Deng Y; Huang WQ; Guo Q; Yang CD; Gu YY; Bao CD; Chen SL
    Clin Rheumatol; 2007 Oct; 26(10):1647-54. PubMed ID: 17308858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report.
    Cao M; Zhang S; Chu D; Xiao M; Liu X; Yu L; Li J; Huang Y; Fang F
    BMC Pulm Med; 2020 Nov; 20(1):304. PubMed ID: 33213393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.